Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,421 | -53,721 | -235,925 | -127,195 | -74,168 |
| Depreciation Amortization | -2,994 | -989 | -3,073 | -2,566 | -1,703 |
| Accounts payable and accrued liabilities | 745 | 1,155 | -581 | 1,331 | 1,025 |
| Other Working Capital | -5,442 | 3,591 | -8,899 | 4,213 | 5,406 |
| Other Operating Activity | 20,999 | 7,009 | 85,200 | 12,381 | 5,377 |
| Operating Cash Flow | $-99,113 | $-42,955 | $-163,278 | $-111,836 | $-64,063 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -117 | -73 | -36 |
| Purchase Of Investment | -205,340 | -185,804 | -109,072 | -89,000 | -76,142 |
| Sale Of Investment | 77,369 | 36,578 | 178,166 | 139,783 | 103,073 |
| Other Investing Activity | -775 | -775 | -4,590 | 0 | 0 |
| Investing Cash Flow | $-128,746 | $-150,001 | $64,387 | $50,710 | $26,895 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,499 | 1,845 | 236,231 | 235,892 | 1,006 |
| Common Stock Repurchased | N/A | N/A | -491 | -491 | -491 |
| Other Financing Activity | 0 | 0 | -3,804 | -2,984 | -122 |
| Financing Cash Flow | $4,499 | $1,845 | $231,936 | $232,417 | $393 |
| Beginning Cash Position | 375,251 | 375,251 | 242,206 | 242,206 | 242,206 |
| End Cash Position | 151,891 | 184,140 | 375,251 | 413,497 | 205,431 |
| Net Cash Flow | $-223,360 | $-191,111 | $133,045 | $171,291 | $-36,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -99,113 | -42,955 | -163,278 | -111,836 | -64,063 |
| Capital Expenditure | N/A | N/A | -117 | -73 | -36 |
| Free Cash Flow | -99,113 | -42,955 | -163,395 | -111,909 | -64,099 |